A. M. Rapoport

953 total citations
12 papers, 732 citations indexed

About

A. M. Rapoport is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, A. M. Rapoport has authored 12 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Pathology and Forensic Medicine and 5 papers in Physiology. Recurrent topics in A. M. Rapoport's work include Migraine and Headache Studies (10 papers), Sympathectomy and Hyperhidrosis Treatments (5 papers) and Trigeminal Neuralgia and Treatments (5 papers). A. M. Rapoport is often cited by papers focused on Migraine and Headache Studies (10 papers), Sympathectomy and Hyperhidrosis Treatments (5 papers) and Trigeminal Neuralgia and Treatments (5 papers). A. M. Rapoport collaborates with scholars based in United States, United Kingdom and Italy. A. M. Rapoport's co-authors include Menachem Sadeh, Mordechai Lorberboym, R. Gilad, Mona Boaz, Yair Lampl, Ron Dabby, FD Sheftell, Marcelo E. Bigal, SJ Tepper and Richard B. Lipton and has published in prestigious journals such as Neurology, Headache The Journal of Head and Face Pain and Cephalalgia.

In The Last Decade

A. M. Rapoport

12 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. Rapoport United States 10 371 275 221 215 131 12 732
A. Floridi Italy 12 502 1.4× 254 0.9× 266 1.2× 140 0.7× 46 0.4× 16 796
Xiaosu Yang China 13 478 1.3× 247 0.9× 156 0.7× 93 0.4× 29 0.2× 32 734
Michael A. Moskowitz United States 7 347 0.9× 202 0.7× 166 0.8× 52 0.2× 50 0.4× 7 556
Amy R. Tso United Kingdom 10 296 0.8× 171 0.6× 110 0.5× 84 0.4× 42 0.3× 13 470
Nadežda Šternić Serbia 16 281 0.8× 200 0.7× 138 0.6× 120 0.6× 92 0.7× 53 924
Kenneth A. Petersen Denmark 16 716 1.9× 411 1.5× 317 1.4× 96 0.4× 38 0.3× 28 1.0k
Yngve Hallström United States 8 807 2.2× 492 1.8× 265 1.2× 70 0.3× 91 0.7× 11 964
Yannan Fang China 14 271 0.7× 125 0.5× 147 0.7× 145 0.7× 24 0.2× 31 587
Nanna Arngrim Denmark 16 426 1.1× 189 0.7× 173 0.8× 93 0.4× 38 0.3× 25 725
Amanda M. VanDenburgh United States 16 413 1.1× 354 1.3× 287 1.3× 107 0.5× 24 0.2× 21 1.5k

Countries citing papers authored by A. M. Rapoport

Since Specialization
Citations

This map shows the geographic impact of A. M. Rapoport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Rapoport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Rapoport more than expected).

Fields of papers citing papers by A. M. Rapoport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Rapoport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Rapoport. The network helps show where A. M. Rapoport may publish in the future.

Co-authorship network of co-authors of A. M. Rapoport

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Rapoport. A scholar is included among the top collaborators of A. M. Rapoport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Rapoport. A. M. Rapoport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Woldeamanuel, Yohannes W., A. M. Rapoport, & Robert P. Cowan. (2014). What Is the Evidence for the Use of Corticosteroids in Migraine?. Current Pain and Headache Reports. 18(12). 464–464. 13 indexed citations
2.
Lampl, Yair, Mona Boaz, R. Gilad, et al.. (2007). Minocycline treatment in acute stroke. Neurology. 69(14). 1404–1410. 348 indexed citations
3.
Lampl, Yair, Mona Boaz, R. Gilad, et al.. (2007). An open-label, evaluator-blinded study. 2 indexed citations
4.
Rapoport, A. M.. (2006). Acute treatment of headache. The Journal of Headache and Pain. 7(5). 355–359. 13 indexed citations
5.
Martelletti, Paolo, Miguel J. A. Láinez, A. M. Rapoport, et al.. (2005). The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE). The Journal of Headache and Pain. 6(4). 261–263. 26 indexed citations
6.
Rapoport, A. M. & ME Bigal. (2004). ID-migraine. Neurological Sciences. 25(S3). s258–s260. 20 indexed citations
7.
Leone, Massimo, Arne May, Angelo Franzini, et al.. (2004). Deep Brain Stimulation for Intractable Chronic Cluster Headache: Proposals for Patient Selection. Cephalalgia. 24(11). 934–937. 109 indexed citations
8.
Bigal, Marcelo E., Richard B. Lipton, SJ Tepper, A. M. Rapoport, & FD Sheftell. (2004). Primary chronic daily headache and its subtypes in adolescents and adults. Neurology. 63(5). 843–847. 105 indexed citations
9.
Sheftell, Fred D., et al.. (1999). Naratriptan in the Prophylaxis of Transformed Migraine. Headache The Journal of Head and Face Pain. 39(7). 506–510. 20 indexed citations
10.
Rapoport, A. M., et al.. (1995). Oral sumatriptan for the long-term treatment of migraine: clinical findings.. PubMed. 45(8 Suppl 7). S15–20. 32 indexed citations
11.
Mathew, N. T., J.R. Couch, Walter Flamenbaum, et al.. (1992). Dose Ranging Efficacy and Safety of Subcutaneous Sumatriptan in the Acute Treatment of Migraine. Archives of Neurology. 49(12). 1271–1276. 43 indexed citations
12.
Kudrow, Lee, et al.. (1987). Advances in the treatment of headache.. PubMed. 90(6). 54, 56, 58–54, 56, 58. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026